MarketWatch.com - Top Stories

FDA says Ozempic and Wegovy shortage is ending. That’s bad news for this wellness stock.

“We will continue to offer access to personalized treatments as allowed by law to meet patient needs,” Hims & Hers CEO said.

Feb 21, 2025 - 19:40
 0
FDA says Ozempic and Wegovy shortage is ending. That’s bad news for this wellness stock.
“We will continue to offer access to personalized treatments as allowed by law to meet patient needs,” Hims & Hers CEO said.
Read More

Tags:

Previous Article

Price analysis 2/21: BTC, ETH, XRP, BNB, SOL, DOGE, ADA, LINK, SUI, XLM

Next Article

Analyst Report: D.R. Horton Inc.

Related Posts

Hot CPI reignites stagflation fears. Here’s why that would be disastrous for your 401(k).

Hot CPI reignites stagflation fears. Here’s why that wo...

Feb 12, 2025  0

These cheap Europe markets could make you more money than the usual picks

These cheap Europe markets could make you more money th...

Feb 12, 2025  0

Hasbro’s stock rallies as it shrugs off tariff impacts on new product launches

Hasbro’s stock rallies as it shrugs off tariff impacts ...

Feb 20, 2025  0